# OTX-DED for the Short-term Treatment of the Symptoms of Dry Eye Disease (DED)

> **NCT05814757** · PHASE2 · COMPLETED · sponsor: **Ocular Therapeutix, Inc.** · enrollment: 100 (actual)

## Conditions studied

- Dry Eye Syndromes
- Eye Diseases

## Interventions

- **DRUG:** OTX-DED
- **DRUG:** Controlled Insertion
- **DRUG:** Collagen Punctal Plug

## Key facts

- **NCT ID:** NCT05814757
- **Lead sponsor:** Ocular Therapeutix, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-11
- **Primary completion:** 2024-05-22
- **Final completion:** 2024-05-22
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2024-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05814757

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05814757, "OTX-DED for the Short-term Treatment of the Symptoms of Dry Eye Disease (DED)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05814757. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*